The mother received a complete course of Betamethasone prior to delivery.
On day of life #1 he transitioned to nasopharyngeal continuous positive airway pressure.
He then weaned to nasal cannula oxygen on day of life #4 and then weaned successfully to room air on day of life #5 where he remained for the rest of his Neonatal Intensive Care Unit stay.
[**Known lastname 2398**] was treated with caffeine citrate for apnea of prematurity from day of life #3 until day of life #25.
Enteral feeds were begun on day of life #2.
He reached full volume feedings on day of life #14 and then was increased from to a maximum calorie enhanced formula  of 26 cal/oz.
At the time of discharge he is eating standard formula of 24 cal/oz on an ad lib schedule with consistent weight gain.
Gastrointestinal status - [**Known lastname 2398**] was treated with phototherapy for hyperbilirubinemia of prematurity from day of life #2 until day of life #11.
He is receiving supplemental iron of 2 mg/kg/day.
He has received no blood product transfusions during his Neonatal Intensive Care Unit stay.
Infectious disease status - [**Known lastname 2398**] was started on Ampicillin and Gentamicin at the time of admission for sepsis risk factor.
The antibiotics were discontinued after 48 hours when the infant was clinically well and the blood cultures negative.
On day of life #20, he completed a five day course of Erythromycin ophthalmic ointment for conjunctivitis.
There were no other infectious disease issues, except that the infant was colonized on routine surveillance surface cultures with Methicillin-resistant Staphylococcus aureus.
Feedings - 24 cal/oz formula on an ad lib schedule.
Medications - Iron sulfate (25 mg/ml 0.2 cc p.o.
Immunizations - The infant has received his first hepatitis B vaccine on [**2152-3-3**] and his first Snyagis on [**2152-3-11**].
Recommended immunizations - I.  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  A.
Influenza immunizations should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other caregivers should be considered for immunization against influenza to protect the infant.
Status post prematurity at 31 1/7 weeks.
Status post circumcision on [**2152-3-8**].
